Jain, H., Karulkar, A., Kalra, D., Ravikumar, S., Vaibhaw, A., Shah, S., Firfiray, A., Pendhari, J., Melinkeri, S., Bhargava, R., Siddarthan, N., Bhurani, D. D., P.K., J., Kaul, E., Mehta, P., Menon, H., Bagal, B., Goyal, K., Shekhawat, P., Boyella, P. K., Boya, R., Abhinav, R., Ahmed, R., Aribandi, A., Nair, A. V., Nair, C., Palaparthi, H., Nayak, L., Singh, P., Pachauri, P., Bhattacharya, R., Kumar, R., Sahoo, R., Damodar, S., Mathews, V., Goli, V. B., Charan, A., Gupta, A., Kapoor, A., Chakrapani, A., Bakshi, A., Nair, B. P., Kazi, B., Chattopadhyay, D., Jaishetwar, G. S., Kalra, K., Kumar, K., K.S, L., Danthala, M., Kalashetty, M., Anukonda, N., Gupta, N., Dhingra, N., Lokireddy, P., Narayanan, P., Karunakaran, P., Ganesan, P., Jain, P., Samal, P., N.V., R., Kapoor, R., Aggarwal, S., Palatty, R. J., Bhethanabhotla, S., Almel, S., Devadas, S., Janakiraman, S., V, S., Vasudevan, S., Tulpule, S., Chiraniya, S., Patil, V., Chaudhry, S., Raja, T., Cyriac, S., Seth, S., Subash, C., Rajan, V., Shetty, A., Sathyanarayanan, V., Ansari, M. S., Tiwari, N., Darbar, S., Chawkekar, S., Sahay, S., Sundharam, M., Saroha, A., Basu, M., Jaiswal, A., Yadav, Y., Soni, S., Thorat, J., Purwar, S., Shah, N., Fry, T., Jain, N., Neelapu, S., Sengar, M., Purwar, R. (2025). Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.. Blood. https://doi.org/10.1182/blood-2025-6288